Showing results (121-130 of 183) with videos related to
Sort By:
Pageof 19
Iscience|February 21, 2024
tANCHOR-cell-based assay for monitoring of SARS-CoV-2 neutralizing antibodies rapidly adaptive to various receptor-binding domainsDaniel Ivanusic, Josef Maier, Suheda Icli, et al.Viruses|October 26, 2024
Prevalence of Antibodies against Adeno-Associated Viruses (AAVs) in Göttingen Minipigs and Its Implications for Gene Therapy and XenotransplantationKirsten Rosenmay Jacobsen, Javier Mota, Michelle Salerno, et al.AIDS Research and Human Retroviruses|January 8, 2014
Immunization with hybrid proteins containing the membrane proximal external region of HIV-1Nicola Strasz, Vladimir A Morozov, Jürgen Kreutzberger, et al.Virus Research|November 7, 2016
No PERV transmission during a clinical trial of pig islet cell transplantationVladimir A Morozov, Shaun Wynyard, Shinichi Matsumoto, et al.Viruses|April 12, 2020
Copy Number and Prevalence of Porcine Endogenous Retroviruses (PERVs) in German Wild BoarsLuise Krüger, Milena Stillfried, Carolin Prinz, et al.Transplantation|December 22, 2020
Pathways to Clinical Cardiac XenotransplantationBruno Reichart, Matthias Längin, Joachim Denner, et al.Biotechniques|December 14, 2020
tANCHOR: a novel mammalian cell surface peptide display systemDaniel Ivanusic, Kazimierz Madela, Heidi Burghard, et al.Biology Methods & Protocols|December 13, 2023
tANCHOR fast and cost-effective cell-based immunization approach with focus on the receptor-binding domain of SARS-CoV-2Hubert Bernauer, Anja Schlör, Josef Maier, et al.Micropublication Biology|May 3, 2024
Analysis of antibodies from whole-cell immunization by a tANCHOR cell-based ELISAHubert Bernauer, Anja Schlör, Josef Maier, et al.Annals of Transplantation|July 27, 2010
Characterisation of a human cell-adapted porcine endogenous retrovirus PERV-A/CAlexander Karlas, Markus Irgang, Jörg Votteler, et al.Pageof 19